BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Fatty liver
1
Liver function improvement after human placental extract injections in patients with chronic liver disease: Thirty case reports
6/4/2025 7:41:49 AM | Browse: 44 | Download: 303
2
Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease
3/14/2024 5:31:16 PM | Browse: 220 | Download: 1194
3
Fatty liver and celiac disease: Why worry?
5/24/2023 9:31:05 AM | Browse: 297 | Download: 859
4
Diabetes and fatty liver: Involvement of incretin and its benefit for fatty liver management
5/15/2023 3:23:22 PM | Browse: 297 | Download: 945
5
In vivo recognition of bioactive substances of Polygonum multiflorum for protecting mitochondria against metabolic dysfunction-associated fatty liver disease
1/4/2023 5:53:02 AM | Browse: 355 | Download: 1162
6
Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis
9/15/2022 1:37:25 PM | Browse: 502 | Download: 1138
7
How to select the quantitative magnetic resonance technique for subjects with fatty liver: A systematic review
8/26/2022 9:54:52 AM | Browse: 376 | Download: 1152
8
Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
8/26/2022 9:51:35 AM | Browse: 537 | Download: 1187
9
Factors early in life associated with hepatic steatosis
6/23/2022 2:39:01 PM | Browse: 585 | Download: 1457
10
Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis
4/29/2022 11:12:04 AM | Browse: 627 | Download: 1145
11
Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
11/24/2021 9:54:22 AM | Browse: 614 | Download: 1583
12
Machine learning models for predicting non-alcoholic fatty liver disease in the general United States population: NHANES database
10/22/2021 1:53:28 PM | Browse: 640 | Download: 1676
13
Standard liver weight model in adult deceased donors with fatty liver: A prospective cohort study.
10/20/2021 7:18:39 AM | Browse: 547 | Download: 1354
14
Impact of COVID-19 on liver
9/16/2021 8:48:21 AM | Browse: 558 | Download: 995
15
Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
8/20/2021 9:33:19 AM | Browse: 845 | Download: 1797
16
Prevalence and risk factors of steatosis and advanced fibrosis using transient elastography in the United States’ adolescent population
7/23/2021 8:10:13 AM | Browse: 708 | Download: 1637
17
Non-alcoholic fatty liver disease and COVID-19: An epidemic that begets pandemic
5/26/2021 9:58:01 AM | Browse: 562 | Download: 1295
18
Metabolic complications of hepatitis C virus infection
3/30/2021 7:03:44 AM | Browse: 665 | Download: 1441
19
Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver
12/18/2020 5:58:43 AM | Browse: 866 | Download: 1845
20
Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
12/18/2020 5:58:43 AM | Browse: 898 | Download: 1503
21
Fatty liver is an independent risk factor for gallbladder polyps
11/27/2020 9:27:48 AM | Browse: 906 | Download: 2194
22
Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis
11/24/2020 12:41:21 PM | Browse: 752 | Download: 2119
23
Relationship between non-alcoholic fatty liver disease and coronary heart disease
10/26/2020 9:59:39 AM | Browse: 785 | Download: 1597
24
Can gadoxetic acid–enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease?
9/21/2020 4:02:08 PM | Browse: 701 | Download: 2375
25
Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update
8/25/2020 9:16:00 AM | Browse: 796 | Download: 1751
26
Medications in type-2 diabetics and their association with liver fibrosis
6/21/2020 2:15:44 PM | Browse: 780 | Download: 1644
27
Non-alcoholic fatty liver disease and Atherosclerosis at a crossroad: The overlap of a theory of change and bioinformatics
5/12/2020 3:08:42 AM | Browse: 897 | Download: 1610
28
Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population
4/23/2020 10:34:55 AM | Browse: 909 | Download: 1976
29
Single strain probiotics for dyslipidemia, fatty liver, and obesity: A systematic review and meta-analysis
6/30/2019 3:51:24 AM | Browse: 1312 | Download: 2534
30
C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population
8/27/2018 7:22:43 AM | Browse: 1206 | Download: 2000
31
Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children
7/19/2018 7:04:34 AM | Browse: 1244 | Download: 2394
32
Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical research
3/4/2018 12:36:47 PM | Browse: 1618 | Download: 2008
33
Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina
1/26/2018 8:09:36 AM | Browse: 1375 | Download: 2216
34
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
12/20/2017 2:49:19 AM | Browse: 1556 | Download: 2031
35
Antioxidant dietary approach in treatment of fatty liver: New insights and updates
6/20/2017 12:12:52 PM | Browse: 1287 | Download: 2403
36
Coffee: The magical bean for liver diseases
5/19/2017 9:53:34 AM | Browse: 1413 | Download: 2052
37
Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease
1/12/2017 1:49:00 PM | Browse: 1895 | Download: 2064
38
Mitochondrial carnitine palmitoyl transferase-Ⅱ inactivity aggravates lipid accumulation in rat hepatocarcinogenesis
1/12/2017 1:49:00 PM | Browse: 1451 | Download: 2209
39
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV
11/26/2016 6:56:00 PM | Browse: 1515 | Download: 2092
40
Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease
11/25/2016 9:02:00 AM | Browse: 1516 | Download: 2648
41
Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
9/30/2016 5:59:00 PM | Browse: 1413 | Download: 1970
42
Iron and non-alcoholic fatty liver disease
9/26/2016 8:04:00 AM | Browse: 1470 | Download: 1993
43
Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-Ⅰ dysfunction
5/19/2016 9:54:00 AM | Browse: 1192 | Download: 2724
44
Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease
12/2/2015 12:01:00 PM | Browse: 1569 | Download: 1936
45
Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the future
11/9/2015 6:35:00 PM | Browse: 1461 | Download: 2104
46
Dietary approach in the treatment of nonalcoholic fatty liver disease
10/30/2015 11:57:00 AM | Browse: 1128 | Download: 1923
47
Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions
8/17/2015 11:14:00 AM | Browse: 1195 | Download: 2626
48
Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review
8/8/2015 2:17:00 PM | Browse: 1619 | Download: 2308
49
Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance
6/29/2015 4:40:00 PM | Browse: 1312 | Download: 1713
50
Non-alcoholic fatty liver disease in 2015
6/16/2015 2:22:00 PM | Browse: 1353 | Download: 2213
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345